Clinical significance of BRAF mutations in metastatic melanoma

Forty to eighty percent of melanoma tumors have activating mutations in BRAF although the clinical importance of these mutations is not clear. We previously reported an analysis of BRAF mutations in metastatic melanoma samples from 68 patients. In this study, we correlated patient baseline character...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chang, David Z, Panageas, Katherine S, Osman, Iman, Polsky, David, Busam, Klaus, Chapman, Paul B
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2004
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC544849/
https://ncbi.nlm.nih.gov/pubmed/15613230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-2-46
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi